grants_govRFA-MH-27-135
Open
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
- Response deadline
- Oct 11, 2026 Due in 39 days
- Date posted
- Apr 29, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to elucidate the key components of the therapeutic effects of rapid-acting psychotropic interventional drugs (RAPIDs) by addressing the methodological challenges involved with these clinical trials. In addition, this NOFO seeks to advance understanding of how RAPIDs and adjunctive psychosocial interventions can be optimally delivered, monitored, and sustained over time to enhance effectiveness and generalizability. The NOFO will support studies designed to enhance the rigor of RAPID clinical trial design, which will ultimately increase the interpretability of the data and the generalizability of the results.
Classifications
- NAICS93.242
Documents (1)
- DownloadRFA-MH-27-135-Revised-Full-Announcement.htmltext/html;charset=UTF-8121 KB
Contacts
Similar contracts
- Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)Due Oct 22, 2026
- Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)Due Oct 15, 2026
- Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)Due Oct 20, 2028
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)Due Feb 11, 2027
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)Due Apr 9, 2027
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)Due Oct 25, 2027